Urokinase plasminogen activator receptor (CD87) expression of tumor-associated macrophages in ductal carcinoma in situ, breast cancer, and resident macrophages of normal breast tissue.
about
Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapyInfluence of Immune Myeloid Cells on the Extracellular Matrix During Cancer MetastasisIdentification of a New Epitope in uPAR as a Target for the Cancer Therapeutic Monoclonal Antibody ATN-658, a Structural Homolog of the uPAR Binding Integrin CD11b (αM)NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis.Expression of proteinases and inhibitors in human breast cancer progression and survival.Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging.Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors.Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis.A cross-talk between NFAT and NF-κB pathways is crucial for nickel-induced COX-2 expression in Beas-2B cellsAmplification of the urokinase-type plasminogen activator receptor (uPAR) gene in ductal pancreatic carcinomas identifies a clinically high-risk group.Receptor-targeted nanoparticles for in vivo imaging of breast cancer.Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic.Collaborating with the enemy: function of macrophages in the development of neoplastic disease.
P2860
Q24805285-DBBCD668-278D-45F6-83E2-8FC2F247A1ACQ26767150-070F34DF-D750-4E04-A801-C87E3579EC36Q27681464-EEE5C14D-A421-4093-A289-6E7E1307A6D2Q33852340-C306A7E8-B684-47B1-9A71-20A2F390C8CFQ33919059-A6394E23-A6D0-4B2C-A4ED-3F052B51492CQ34069767-2E52F8A2-F17A-4A78-81BC-D88F23976676Q35580568-3F1BC58C-1CFA-4D39-8DBA-39862088D101Q35990029-6F49F42F-F255-4945-98BD-9E5F85A2107BQ36198192-4CB0E2D9-06C4-4B39-9DBD-C2F7E77086FDQ36972901-FE7B1CC0-6437-413A-A9F6-5F07364EC523Q37137516-4B0F8188-4A93-4F03-9B87-235A06D3761CQ37197386-3487619F-BD44-4F83-B3D4-FCC599592025Q37307237-1E95A60E-4236-4272-A89F-6743E36BD952Q37895294-2E5EABE5-F41E-41D0-9E85-44AEDED7ED8DQ38098161-029D063A-7FC9-45E7-B72F-198746526695
P2860
Urokinase plasminogen activator receptor (CD87) expression of tumor-associated macrophages in ductal carcinoma in situ, breast cancer, and resident macrophages of normal breast tissue.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Urokinase plasminogen activato ...... hages of normal breast tissue.
@ast
Urokinase plasminogen activato ...... hages of normal breast tissue.
@en
type
label
Urokinase plasminogen activato ...... hages of normal breast tissue.
@ast
Urokinase plasminogen activato ...... hages of normal breast tissue.
@en
prefLabel
Urokinase plasminogen activato ...... hages of normal breast tissue.
@ast
Urokinase plasminogen activato ...... hages of normal breast tissue.
@en
P2093
P1476
Urokinase plasminogen activato ...... hages of normal breast tissue.
@en
P2093
P577
1999-07-01T00:00:00Z